Skip to main content
Medpace Holdings, Inc. logo

Medpace Holdings, Inc. — Investor Relations & Filings

Ticker · MEDP ISIN · US58506Q1094 LEI · 549300H8TYEUVTW14A54 US Professional, scientific and technical activities
Open in API
Filings indexed 858 across all filing types
Latest filing 2026-05-19 Declaration of Voting R…
Country US United States of America
Listing US MEDP

About Medpace Holdings, Inc.

https://investor.medpace.com/

Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization (CRO) that provides Phase I-IV clinical development services. The company serves the biotechnology, pharmaceutical, and medical device industries, with a mission to accelerate the development of safe and effective medical therapeutics. Medpace employs a disciplined operating approach that leverages regulatory and therapeutic expertise. Its services include clinical pharmacology, central laboratory, bioanalytical, ECG core lab, and imaging core labs. The company has expertise across major therapeutic areas, including oncology, cardiology, metabolic disease, endocrinology, central nervous system, and anti-viral and anti-infective diseases.

Recent filings

Filing Released Lang Actions
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 89% confidence The document is a Form 8-K reporting two main items: (1) amendments to the company’s Certificate of Incorporation and Bylaws (Item 5.03), and (2) the submission of various proposals at the 2026 Annual Meeting along with detailed vote tallies (Item 5.07). The bulk of the text consists of the official shareholder voting results for multiple proposals. This matches the filing definition for Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-05-19 English
10-Q - Medpace Holdings, Inc. (0001668397) (Filer)
Interim / Quarterly Report Q1 2026
2026-04-23 English
8-K - Medpace Holdings, Inc. (0001668397) (Filer)
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce significant events. The text includes Item 2.02 Results of Operations and Financial Condition, which references a press release announcing quarterly financial results for the three months ended March 31, 2026. The document also includes Item 5.02 regarding the departure of a director/officer. The document does not contain the full financial statements or detailed financial analysis itself but rather references a press release and announces management changes. Form 8-K filings are typically regulatory filings reporting current events and are not full financial reports or earnings releases themselves. The presence of management change information and a reference to a press release of financial results supports classification as a Regulatory Filing (RNS). The document length is under 5,000 characters, and it references an attached press release rather than containing the full earnings release text, so it is not an Earnings Release (ER). Therefore, the best classification is Regulatory Filings (RNS).
2026-04-22 English
ARS - Medpace Holdings, Inc. (0001668397) (Filer)
Annual Report
2026-04-01 English
SCHEDULE 13G/A - Medpace Holdings, Inc. (0001668397) (Subject)
Major Shareholding Notification
2026-03-27 English
4 - Medpace Holdings, Inc. (0001668397) (Issuer)
Director's Dealing
2026-03-19 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.